Skip to main content
Top
Published in: International Archives of Occupational and Environmental Health 2/2007

Open Access 01-11-2007 | Original Article

Assessment of lipid, hepatic, and thyroid parameters with serum perfluorooctanoate (PFOA) concentrations in fluorochemical production workers

Authors: Geary W. Olsen, Larry R. Zobel

Published in: International Archives of Occupational and Environmental Health | Issue 2/2007

Login to get access

Abstract

Objectives

Perfluorooctanoic acid (PFOA) results in peroxisome proliferator mediated effects in rats and mice resulting in hypolipidemia but not in monkeys. Counterintuitive modestly positive associations between PFOA and cholesterol levels in production workers have been inconsistently reported. The purpose of this assessment was to examine this association in male workers who manufactured or used PFOA at three facilities.

Methods

Subjects were male employee voluntary participants of a fluorochemical medical surveillance program who provided blood samples for serum measurement of PFOA (perfluorooctanoate) and various lipid, hepatic, and thyroid parameters. Statistical analyses included multiple and logistic regression and analysis of covariance.

Results

A total of 506 employees, who did not take cholesterol-lowering medications (93% of all male participants), were analyzed. Serum PFOA concentrations ranged from 0.007 to 92.03 μg/ml [arithmetic mean 2.21 μg/ml (95% confidence interval 1.66–2.77), median 1.10 μg/ml]. Adjusted for age, body mass index, and alcohol usage in regression analyses, PFOA was not statistically significantly (P > 0.05) associated with total cholesterol or low-density lipoproteins (LDL). High-density lipoproteins (HDL) were significantly negatively (P < 0.01) associated with PFOA for the three facilities combined but not by individual sites, indicating the overall result was likely a consequence of residual confounding due to different demographic profiles at these sites. Serum triglycerides were significantly positively associated with PFOA but not consistently by locations. There were no statistically significant associations observed between PFOA and hepatic enzymes for the three facilities combined although some modest positive associations were observed between PFOA and hepatic enzymes at one of the three facilities. Analyses of all locations showed no associations with TSH or T4 and PFOA. A negative association was observed for free T4 and positive association for T3; however, the findings were well within these assays’ normal reference ranges.

Conclusion

There was no evidence that employees’ serum PFOA concentrations were associated with total cholesterol or LDL. A negative association with HDL was explained by demographic differences across the three locations. Several explanations are offered for the inconsistent triglyceride associations with PFOA including both methodological as well as biological possibilities.
Literature
go back to reference Alexander BH, Grice M (2006) Self-reported medical conditions in perfluorooctanesulfonyl fluoride manufacturing workers. University of Minnesota, Minneapolis, 1 February, 2006. US EPA docket AR-226-3677. US Environmental Protection Agency, Washington, DC Alexander BH, Grice M (2006) Self-reported medical conditions in perfluorooctanesulfonyl fluoride manufacturing workers. University of Minnesota, Minneapolis, 1 February, 2006. US EPA docket AR-226-3677. US Environmental Protection Agency, Washington, DC
go back to reference Alexander BH, Olsen GW, Burris JM, Mandel JH, Mandel JS (2003) Mortality of employees of a perfluorooctanesulphonyl fluoride manufacturing facility. Occup Environ Med 60:722–729PubMedCrossRef Alexander BH, Olsen GW, Burris JM, Mandel JH, Mandel JS (2003) Mortality of employees of a perfluorooctanesulphonyl fluoride manufacturing facility. Occup Environ Med 60:722–729PubMedCrossRef
go back to reference Al-Naimi S, Hampton SM, Richard P, Tzung C, Morgan LM (2004) Postprandial metabolic profiles following meals and snacks eaten during simulated night and day shift work. Chronobiol Int 21:937–947PubMedCrossRef Al-Naimi S, Hampton SM, Richard P, Tzung C, Morgan LM (2004) Postprandial metabolic profiles following meals and snacks eaten during simulated night and day shift work. Chronobiol Int 21:937–947PubMedCrossRef
go back to reference Brousseau ME, Schaefer EJ, Wolfe ML, Bloedon LT, Digenio AG, Clark RW, Mancuso JP, Rader DJ (2004) Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol. N Engl J Med 350:1505–1515PubMedCrossRef Brousseau ME, Schaefer EJ, Wolfe ML, Bloedon LT, Digenio AG, Clark RW, Mancuso JP, Rader DJ (2004) Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol. N Engl J Med 350:1505–1515PubMedCrossRef
go back to reference Butenhoff J, Costa G, Elcombe C, Farrar D, Hansen K, Iwai H, Jung R, Kennedy G, Lieder P, Olsen G, Thomford P (2002) Toxicity of ammonium perfluorooctanoate in male cynomolgus monkeys after oral dosing for 6 months. Toxicol Sci 69:244–257PubMedCrossRef Butenhoff J, Costa G, Elcombe C, Farrar D, Hansen K, Iwai H, Jung R, Kennedy G, Lieder P, Olsen G, Thomford P (2002) Toxicity of ammonium perfluorooctanoate in male cynomolgus monkeys after oral dosing for 6 months. Toxicol Sci 69:244–257PubMedCrossRef
go back to reference Calafat AM, Kuklenyik Z, Caudill SP, Reidy JA, Needham LL (2006) Perfluorochemicals in pooled serum samples from United States residents in 2001 and 2002. Environ Sci Technol 40:2128–2134PubMedCrossRef Calafat AM, Kuklenyik Z, Caudill SP, Reidy JA, Needham LL (2006) Perfluorochemicals in pooled serum samples from United States residents in 2001 and 2002. Environ Sci Technol 40:2128–2134PubMedCrossRef
go back to reference Chang SC, Thibodeaux JR, Eastvold ML, Ehresman DJ, Bjork JA, Froehlich JW, Lau CS, Singh RJ, Wallace KB, Butenhoff JL (2007) Negative bias from analog methods used in the analysis of free thyroxine in rat serum containing perfluorooctanesulfonate (PFOS). Toxicology 234:21–33PubMedCrossRef Chang SC, Thibodeaux JR, Eastvold ML, Ehresman DJ, Bjork JA, Froehlich JW, Lau CS, Singh RJ, Wallace KB, Butenhoff JL (2007) Negative bias from analog methods used in the analysis of free thyroxine in rat serum containing perfluorooctanesulfonate (PFOS). Toxicology 234:21–33PubMedCrossRef
go back to reference Clark JM, Brancati FL, Diehl AM (2003) The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 98:960–967PubMedCrossRef Clark JM, Brancati FL, Diehl AM (2003) The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 98:960–967PubMedCrossRef
go back to reference Collantes R, Ong JP, Younossi ZM (2004) Nonalcoholic fatty liver disease and the epidemic of obesity. Cleve Clin J Med 71:657–664PubMedCrossRef Collantes R, Ong JP, Younossi ZM (2004) Nonalcoholic fatty liver disease and the epidemic of obesity. Cleve Clin J Med 71:657–664PubMedCrossRef
go back to reference Costa G (2004) Letter. US EPA docket AR226-1868. US Environmental Protection Agency, Washington, DD Costa G (2004) Letter. US EPA docket AR226-1868. US Environmental Protection Agency, Washington, DD
go back to reference De Silva AO, Mabury SA (2006) Isomer distribution of perfluorocarboxylates in human blood: potential correlation to source. Environ Sci Technol 40:2903–2909PubMedCrossRef De Silva AO, Mabury SA (2006) Isomer distribution of perfluorocarboxylates in human blood: potential correlation to source. Environ Sci Technol 40:2903–2909PubMedCrossRef
go back to reference Emmett EA, Zhang H, Shofer FS, Freeman D, Rodway NV, Desai C, Shaw LM (2006a) Community exposure to perfluorooctanoate: relationships between serum levels and certain health parameters. JOEM 48:771–779PubMedCrossRef Emmett EA, Zhang H, Shofer FS, Freeman D, Rodway NV, Desai C, Shaw LM (2006a) Community exposure to perfluorooctanoate: relationships between serum levels and certain health parameters. JOEM 48:771–779PubMedCrossRef
go back to reference Emmett EA, Zhang H, Shofer FS, Freeman D, Rodway NV, Desai C, Shaw LM (2006b) Community exposure to perfluorooctanoate: relationships between serum concentrations and exposure sources. JOEM 48:759–770PubMedCrossRef Emmett EA, Zhang H, Shofer FS, Freeman D, Rodway NV, Desai C, Shaw LM (2006b) Community exposure to perfluorooctanoate: relationships between serum concentrations and exposure sources. JOEM 48:759–770PubMedCrossRef
go back to reference Expert Panel (2001) Executive summary of the third report of the National Cholesterol Education Program (CNCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285:2486–2497CrossRef Expert Panel (2001) Executive summary of the third report of the National Cholesterol Education Program (CNCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285:2486–2497CrossRef
go back to reference Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 18:499–502PubMed Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 18:499–502PubMed
go back to reference Gilliland FD, Mandel JS (1996) Serum perfluorooctanoic acid and hepatic enzymes, lipoproteins and cholesterol: a study of occupationally exposed men. Am J Ind Med 129:560–568CrossRef Gilliland FD, Mandel JS (1996) Serum perfluorooctanoic acid and hepatic enzymes, lipoproteins and cholesterol: a study of occupationally exposed men. Am J Ind Med 129:560–568CrossRef
go back to reference Han X, Snow TA, Kemper RA, Jepson GW (2003) Binding of perfluorooctanoic acid to rat and human plasma proteins. Chem Res Toxicol 16:775–781PubMedCrossRef Han X, Snow TA, Kemper RA, Jepson GW (2003) Binding of perfluorooctanoic acid to rat and human plasma proteins. Chem Res Toxicol 16:775–781PubMedCrossRef
go back to reference Hansen KJ, Clemen LA, Ellefson ME, Johnson HO (2001) Compound-specific quantitative characterization of organic fluorochemicals in biological matrices. Environ Sci Technol 35:766–770PubMedCrossRef Hansen KJ, Clemen LA, Ellefson ME, Johnson HO (2001) Compound-specific quantitative characterization of organic fluorochemicals in biological matrices. Environ Sci Technol 35:766–770PubMedCrossRef
go back to reference Hernán MA, Hernández-Diaz S, Werler MM, Mitchell AA (2002) Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology. Am J Epidemiol 155:176–184PubMedCrossRef Hernán MA, Hernández-Diaz S, Werler MM, Mitchell AA (2002) Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology. Am J Epidemiol 155:176–184PubMedCrossRef
go back to reference Kaplan AM (2004) Ammonium perfluorooctanoate. US EPA docket AR-226-1867 and AR 226-1868. US Environmental Protection Agency, Washington, DC Kaplan AM (2004) Ammonium perfluorooctanoate. US EPA docket AR-226-1867 and AR 226-1868. US Environmental Protection Agency, Washington, DC
go back to reference Karlsson B, Knutsson A, Lindahl B (2001) Is there an association between shift work and having a metabolic syndrome? Results from a population based study of 27,485 people. Occup Environ Med 58:747–752PubMedCrossRef Karlsson B, Knutsson A, Lindahl B (2001) Is there an association between shift work and having a metabolic syndrome? Results from a population based study of 27,485 people. Occup Environ Med 58:747–752PubMedCrossRef
go back to reference Karlsson BH, Knutsson AK, Lindahl BO, Alfredsson LS (2003) Metabolic disturbances in male workers with rotating three-shift work. Results of the WOLF study. Int Arch Occup Environ Health 76:424–430PubMedCrossRef Karlsson BH, Knutsson AK, Lindahl BO, Alfredsson LS (2003) Metabolic disturbances in male workers with rotating three-shift work. Results of the WOLF study. Int Arch Occup Environ Health 76:424–430PubMedCrossRef
go back to reference Kennedy GL, Butenhoff JL, Olsen GW, O’Connor JC, Seacat AM, Perkins RG, Biegel LB, Murphy SR, Farrar DG (2004) The toxicology of perfluorooctanoate. Crit Rev Toxicol 34:351–384PubMedCrossRef Kennedy GL, Butenhoff JL, Olsen GW, O’Connor JC, Seacat AM, Perkins RG, Biegel LB, Murphy SR, Farrar DG (2004) The toxicology of perfluorooctanoate. Crit Rev Toxicol 34:351–384PubMedCrossRef
go back to reference Kerstner-Wood C, Coward L, Gorman G (2003) Protein binding of perfluorobutane sulfonate, perfluorohexane sulfonate, perfluorooctane sulfonate and perfluorooctanoate to plasma (human, rat, and monkey), and various human-derived plasma protein fractions. Southern Research Institute. Study 9921.7. US EPA docket AR-226-1354. US Environmental Protection Agency, Washington, DC Kerstner-Wood C, Coward L, Gorman G (2003) Protein binding of perfluorobutane sulfonate, perfluorohexane sulfonate, perfluorooctane sulfonate and perfluorooctanoate to plasma (human, rat, and monkey), and various human-derived plasma protein fractions. Southern Research Institute. Study 9921.7. US EPA docket AR-226-1354. US Environmental Protection Agency, Washington, DC
go back to reference Lund J, Arendt J, Hampton SM, English J, Morgan LM (2001) Postprandial hormone and metabolic responses amongst shift workers in Antarctica. J Endocrinol 171:557–564PubMedCrossRef Lund J, Arendt J, Hampton SM, English J, Morgan LM (2001) Postprandial hormone and metabolic responses amongst shift workers in Antarctica. J Endocrinol 171:557–564PubMedCrossRef
go back to reference Maloney EK, Waxman DJ (1999) Transactivation of PPARα and PPARγ by structurally diverse environmental chemicals. Toxicol Appl Pharmacol 161:209–218PubMedCrossRef Maloney EK, Waxman DJ (1999) Transactivation of PPARα and PPARγ by structurally diverse environmental chemicals. Toxicol Appl Pharmacol 161:209–218PubMedCrossRef
go back to reference Mofrad PS, Sanyal AJ (2003) Nonalcoholic fatty liver disease. MedGenMed 5:1–13 Mofrad PS, Sanyal AJ (2003) Nonalcoholic fatty liver disease. MedGenMed 5:1–13
go back to reference Morgan L, Arendt J, Owens D, Folkard S, Hampton S, Deacon S, English J, Ribeiro D, Taylor K (1998) Effects of the endogenous clock and sleep time on melatonin, insulin, glucose, and lipid metabolism. J Endocrinol 157:443–451PubMedCrossRef Morgan L, Arendt J, Owens D, Folkard S, Hampton S, Deacon S, English J, Ribeiro D, Taylor K (1998) Effects of the endogenous clock and sleep time on melatonin, insulin, glucose, and lipid metabolism. J Endocrinol 157:443–451PubMedCrossRef
go back to reference Nakanishi N, Matsuo Y, Yoneda H, Nakamur K, Suzuki K, Tatara K (2000) Validity of the conventional indirect methods including Friedewald method for determining serum low-density lipoprotein cholesterol level: comparison with the direct homogeneous enzymatic analysis. J Occup Health 42:130–137CrossRef Nakanishi N, Matsuo Y, Yoneda H, Nakamur K, Suzuki K, Tatara K (2000) Validity of the conventional indirect methods including Friedewald method for determining serum low-density lipoprotein cholesterol level: comparison with the direct homogeneous enzymatic analysis. J Occup Health 42:130–137CrossRef
go back to reference Olsen GW, Zobel LR (2006) An analysis of the 2000 fluorochemical (perfluorooctanoate, PFOA) medical surveillance program at 3M Company’s Antwerp (Belgium), Cottage Grove (Minnesota), and Decatur (Alabama) facilities. 3M Company, St Paul, 6 May, 2006. US EPA docket AR-226-3678. US Environmental Protection Agency, Washington, DC Olsen GW, Zobel LR (2006) An analysis of the 2000 fluorochemical (perfluorooctanoate, PFOA) medical surveillance program at 3M Company’s Antwerp (Belgium), Cottage Grove (Minnesota), and Decatur (Alabama) facilities. 3M Company, St Paul, 6 May, 2006. US EPA docket AR-226-3678. US Environmental Protection Agency, Washington, DC
go back to reference Olsen GW, Gilliland FD, Burlew MM, Burris JM, Mandel JS, Mandel JH (1998) An epidemiologic investigation of reproductive hormones in men with occupational exposure to perfluorooctanoic acid. JOEM 40:614–622PubMedCrossRef Olsen GW, Gilliland FD, Burlew MM, Burris JM, Mandel JS, Mandel JH (1998) An epidemiologic investigation of reproductive hormones in men with occupational exposure to perfluorooctanoic acid. JOEM 40:614–622PubMedCrossRef
go back to reference Olsen GW, Burris JM, Mandel JH, Zobel LR (1999) Serum perfluorooctane sulfonate and hepatic and lipid clinical chemistry tests in fluorochemical production employees. JOEM 42:799–806CrossRef Olsen GW, Burris JM, Mandel JH, Zobel LR (1999) Serum perfluorooctane sulfonate and hepatic and lipid clinical chemistry tests in fluorochemical production employees. JOEM 42:799–806CrossRef
go back to reference Olsen GW, Burris JM, Burlew MM, Mandel JH (2000) Plasma cholecystokinin and hepatic enzymes, cholesterol and lipoproteins in ammonium perfluorooctanoate production workers. Drug Chem Toxicol 23:603–620PubMedCrossRef Olsen GW, Burris JM, Burlew MM, Mandel JH (2000) Plasma cholecystokinin and hepatic enzymes, cholesterol and lipoproteins in ammonium perfluorooctanoate production workers. Drug Chem Toxicol 23:603–620PubMedCrossRef
go back to reference Olsen GW, Burris JM, Burlew MM, Mandel JH (2003a) Epidemiologic assessment of worker serum perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations and medical surveillance examinations. JOEM 45:260–270PubMedCrossRef Olsen GW, Burris JM, Burlew MM, Mandel JH (2003a) Epidemiologic assessment of worker serum perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations and medical surveillance examinations. JOEM 45:260–270PubMedCrossRef
go back to reference Olsen GW, Church TR, Miller JP, Burris JM, Hansen KJ, Lundberg JK, Armitage JB, Herron RM, Medhdizadehkashi Z, Nobiletti JB, O’Neill EM, Mandel JH, Zobel LR (2003b) Perfluorooctanesulfonate and other fluorochemicals in the serum of American Red Cross adult blood donors. Environ Health Perspect 111:1892–1901PubMedCrossRef Olsen GW, Church TR, Miller JP, Burris JM, Hansen KJ, Lundberg JK, Armitage JB, Herron RM, Medhdizadehkashi Z, Nobiletti JB, O’Neill EM, Mandel JH, Zobel LR (2003b) Perfluorooctanesulfonate and other fluorochemicals in the serum of American Red Cross adult blood donors. Environ Health Perspect 111:1892–1901PubMedCrossRef
go back to reference Olsen GW, Butenhoff JL, Mandel JH (2003c) Assessment of lipid, hepatic and thyroid function in relation to an occupational biologic limit value for perfluorooctanoate. 3M Company, St Paul. US EPA docket AR-226-1351. US Environmental Protection Agency, Washington, DC Olsen GW, Butenhoff JL, Mandel JH (2003c) Assessment of lipid, hepatic and thyroid function in relation to an occupational biologic limit value for perfluorooctanoate. 3M Company, St Paul. US EPA docket AR-226-1351. US Environmental Protection Agency, Washington, DC
go back to reference Olsen GW, Burlew MM, Marshall JC, Burris JM, Mandel JH (2004) Analysis of episodes of care in a perfluorooctanesulfonyl fluoride production facility. JOEM 46:837–846PubMedCrossRef Olsen GW, Burlew MM, Marshall JC, Burris JM, Mandel JH (2004) Analysis of episodes of care in a perfluorooctanesulfonyl fluoride production facility. JOEM 46:837–846PubMedCrossRef
go back to reference Ruhl CE, Everhart JE (2003) Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. Gastroenterology 124:71–79PubMedCrossRef Ruhl CE, Everhart JE (2003) Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. Gastroenterology 124:71–79PubMedCrossRef
go back to reference Seacat AM, Thomford PJ, Hansen KJ, Olsen GW, Case MT, Butenhoff JL (2002) Subchronic toxicity studies on perfluorooctanesulfonate potassium salt in cynomolgus monkeys. Toxicol Sci 68:249–264PubMedCrossRef Seacat AM, Thomford PJ, Hansen KJ, Olsen GW, Case MT, Butenhoff JL (2002) Subchronic toxicity studies on perfluorooctanesulfonate potassium salt in cynomolgus monkeys. Toxicol Sci 68:249–264PubMedCrossRef
go back to reference Seacat AM, Thomford PJ, Hansen KJ, Clemens LA, Eldridge SR, Elcombe CR, Butenhoff JL (2003) Sub-chronic dietary toxicity of potassium perfluorooctanesulfonate in rats. Toxicology 183:117–131PubMedCrossRef Seacat AM, Thomford PJ, Hansen KJ, Clemens LA, Eldridge SR, Elcombe CR, Butenhoff JL (2003) Sub-chronic dietary toxicity of potassium perfluorooctanesulfonate in rats. Toxicology 183:117–131PubMedCrossRef
go back to reference Stein EA, Myers GL (1994) Lipids, lipoproteins, and apolipoproteins. In: Burtis CA, Ashwood ER (eds) Tietz textbook of clinical chemistry. WB Saunders Co., Philadelphia, pp 1002–1093 Stein EA, Myers GL (1994) Lipids, lipoproteins, and apolipoproteins. In: Burtis CA, Ashwood ER (eds) Tietz textbook of clinical chemistry. WB Saunders Co., Philadelphia, pp 1002–1093
go back to reference Ubel FA, Sorenson SD, Roach DE (1980) Health status of plant workers exposed to fluorochemicals—a preliminary report. Am Ind Hyg Assoc J 41:584–589PubMed Ubel FA, Sorenson SD, Roach DE (1980) Health status of plant workers exposed to fluorochemicals—a preliminary report. Am Ind Hyg Assoc J 41:584–589PubMed
go back to reference Xie Y, Yang Q, Nelson BD, DePierre JW (2003) The relationship between liver peroxisome proliferation and adipose tissue atrophy induced by peroxisome proliferators exposure and withdrawal in mice. Biochem Pharmacol 66:749–756PubMedCrossRef Xie Y, Yang Q, Nelson BD, DePierre JW (2003) The relationship between liver peroxisome proliferation and adipose tissue atrophy induced by peroxisome proliferators exposure and withdrawal in mice. Biochem Pharmacol 66:749–756PubMedCrossRef
Metadata
Title
Assessment of lipid, hepatic, and thyroid parameters with serum perfluorooctanoate (PFOA) concentrations in fluorochemical production workers
Authors
Geary W. Olsen
Larry R. Zobel
Publication date
01-11-2007
Publisher
Springer-Verlag
Published in
International Archives of Occupational and Environmental Health / Issue 2/2007
Print ISSN: 0340-0131
Electronic ISSN: 1432-1246
DOI
https://doi.org/10.1007/s00420-007-0213-0

Other articles of this Issue 2/2007

International Archives of Occupational and Environmental Health 2/2007 Go to the issue